Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana
Key facts
- Where
- Cape Coast, GhanaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 65 years old?
Source: NCT06800664, who can take part
Where in Ghana
- University of Cape CoastCape Coast, GhanaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Baylor University
- Trial code
- NCT06800664
- Record updated
- 1 July 2026
- Original description
The investigators propose to develop and/or adapt implementation strategies and a structured implementation plan to translate the HOPE intervention into existing healthcare practice in Ghana.Read full original descriptionShow less
The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention Among Women Living With HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial
The investigators propose to develop and/or adapt implementation strategies and a structured implementation plan to translate the HOPE intervention into existing healthcare practice in Ghana.
These "implementation support strategies (ISS)" are implementation strategies relevant to implementation support, which is concerned with moving (implementation) research into (implementation) practice.
The ultimate goal is to facilitate health system adoption and sustainment.
Inclusion: General criteria; ability to give consent per Institutional Review Board stipulations; residing in the Central Region; having no medical characteristics that would interfere with the ability to participate fully; the willingness to participate in this study; (a) Healthcare provider eligibility: Inclusion criteria include an individual (no gender restrictions) who; possesses healthcare qualifications (i.e., patient navigators, physicians, nurses, health facility management),; works at the HIV health facility at study sites,; is ≥18 years old. (b) Eligibility for women living with HIV (Patients); identified female at birth) who; are living with HIV between 25 and 65 years old (age consistent with WHO CC screening guidelines); have never had CC screening (Pap or HPV test),; have not had a screening for the past 5 years.
Exclusion: Women will be excluded if they are pregnant or have had a hysterectomy; WLWH who have a cervix are the main target population to develop the HOPE toolkit; Women who are below 25 and those who are above 65 years will be excluded.